Datta Syamal K, Zhang Li, Xu Luting
Department of Medicine, Feinberg School of Medicine, Northwestern University, 240 East Huron St., Chicago, IL 60611, USA.
J Mol Med (Berl). 2005 Apr;83(4):267-78. doi: 10.1007/s00109-004-0624-2. Epub 2005 Jan 4.
Special populations of T helper cells drive B cells to produce IgG class switched, pathogenic autoantibodies in lupus. The major source of antigenic determinants (epitopes) that trigger interactions between lupus T and B cells is nucleosomes of apoptotic cells. These epitopes can be used for antigen-specific therapy of lupus. Secondly, the autoimmune T cells of lupus are sustained because they resist anergy and activation-induced programmed cell death by markedly upregulating cyclooxygenase (COX) 2 along with the antiapoptotic molecule c-FLIP. Only certain COX-2 inhibitors block pathogenic anti-DNA autoantibody production in lupus by causing death of autoimmune T helper cells. Hence COX-2 inhibitors may work independently of their ability to block the enzymatic function of COX-2, and structural peculiarities of these select inhibitors may lead to better drug discovery and design.
特定亚群的辅助性T细胞促使B细胞产生IgG类别转换的致病性自身抗体,从而引发狼疮。引发狼疮T细胞和B细胞相互作用的抗原决定簇(表位)的主要来源是凋亡细胞的核小体。这些表位可用于狼疮的抗原特异性治疗。其次,狼疮的自身免疫性T细胞得以持续存在,因为它们通过显著上调环氧化酶(COX)2以及抗凋亡分子c-FLIP来抵抗无反应性和激活诱导的程序性细胞死亡。只有某些COX-2抑制剂通过导致自身免疫性辅助性T细胞死亡来阻断狼疮中致病性抗DNA自身抗体的产生。因此,COX-2抑制剂可能独立于其阻断COX-2酶功能的能力发挥作用,并且这些特定抑制剂的结构特性可能有助于更好地进行药物发现和设计。